Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 10/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.47 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.47 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24185740 | 0.86 | SRC (0.57) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL13347464 | 0.86 | SRC (0.57) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL29628001 | 0.86 | SRC (0.66) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL31490482 | 0.86 | SRC (0.57) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL668092 | 0.86 | SRC (0.66) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL3328397 | 0.83 | SRC (0.55) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL22927432 | 0.83 | SRC (0.55) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL718255 | 0.82 | MAPT (0.74) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL3325844 | 0.82 | SRC (0.57) | SRCMAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL11177694 | 0.82 | SRC (0.60) | SRCMAPTMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4116313-A1 | CAP ANALOG FOR THE 5'-END OF EUKARYOTIC MESSENGER RNAS | Westfälische Wilhelms-Universität Münster (DE) | 2023-01-11 | — | — | EP | disclosed |
| US-9832880-B2 | Electronic apparatus and method for manufacturing the same | Innolux Corporation (TW) | 2017-11-28 | — | — | US | disclosed |
| US-20170088573-A1 | GEMCITABINE ANALOGS | NUCORION PHARMACEUTICALS, INC. | 2017-03-30 | — | — | US | disclosed |
| US-9598713-B2 | Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method | JAPANESE SCIENCE AND TECHNOLOGY AGENCY (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20150118713-A1 | METHOD FOR CONSTRUCTING FUNCTIONAL NUCLEIC ACID MOLECULE, AND NUCLEIC ACID COMBINATION TO BE USED IN SAID METHOD | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-04-30 | — | — | US | disclosed |
| US-20140362545-A1 | ELECTRONIC APPARATUS AND METHOD FOR MANUFACTURING THE SAME | Innolux Corporation (TW) | 2014-12-11 | — | — | US | disclosed |
| WO-2012038097-A1 | USE OF A NEW CLASS OF NUCLEOTIDE SUGAR AS ANTIBIOTIC OR CYTOSTATIC AGENT | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2012-03-29 | — | — | WO | disclosed |
| EP-2433948-A1 | Use of a new class of nucleotide sugar as antibiotic or cytostatic agent | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2012-03-28 | — | — | EP | disclosed |
| US-7807670-B2 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM CANADA LTD. (CA) | 2010-10-05 | — | — | US | disclosed |
| US-7807670-B2 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM CANADA LTD. (CA) | 2010-10-05 | — | — | US | disclosed |
| US-7713634-B2 | Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-11 | — | — | US | disclosed |
| US-20100041649-A1 | INHIBITORS OF PAPILLOMA VIRUS | YOAKIM CHRISTIANE | 2010-02-18 | — | — | US | disclosed |
| US-20100041649-A1 | INHIBITORS OF PAPILLOMA VIRUS | YOAKIM CHRISTIANE | 2010-02-18 | — | — | US | disclosed |
| US-7528167-B2 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-05-05 | — | — | US | disclosed |
| US-20080057322-A1 | Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041649-A1 | INHIBITORS OF PAPILLOMA VIRUS | REV1, CDKN1A, RB1 | SRC 1571/4885MAPT 4122/4885MEN1 1085/4885 |
| US-20170088573-A1 | GEMCITABINE ANALOGS | GMNN, RNASE1, TGM3 | SRC 2862/4885MAPT 3891/4885MEN1 729/4885 |
| US-20080057322-A1 | Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same | NONO, SPTBN1, SKIC8 | SRC 1306/4885MAPT 438/4885MEN1 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.